Wuyang Hua
Nanjing, 211189, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A hypoxia-activated NO donor for the treatment of myocardial hypoxia injury.
Journal: Chemical science
Published: January 05, 2022
Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity.
Journal: Journal of medicinal chemistry
Published: February 02, 2021
DNA-Targeting RuII -Polypyridyl Complex with a Long-Lived Intraligand Excited State as a Potential Photodynamic Therapy Agent.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: June 24, 2020
A naphthalimide derivative can release COS and form H2S in a light-controlled manner and protect cells against ROS with real-time monitoring ability.
Journal: The Analyst
Published: April 17, 2020
A lysosome specific theranostic NO donor inhibits cancer cells by stimuli responsive molecular self-decomposition with an on-demand fluorescence pattern.
Journal: The Analyst
Published: October 11, 2019
A study on platinum(iv) species containing an estrogen receptor modulator to reverse tamoxifen resistance of breast cancer.
Journal: Metallomics : integrated biometal science
Published: January 20, 2018
Combination of 7-hydroxycoumarin in a platinum(IV) complex derived from cisplatin enhanced cytotoxicity with multiple mechanisms of action.
Journal: Journal of inorganic biochemistry
Published: November 29, 2017
Biotinylated platinum(IV) complexes designed to target cancer cells.
Journal: Journal of inorganic biochemistry
Published: June 01, 2017
Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance.
Journal: Journal of inorganic biochemistry
Published: November 29, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026